Exposure to toxins can be associated with the development of autoimmunity. An environmental toxin, mercury, has been recently shown to induce glomerulonephritis in rats, mice and rabbits. Autoantibody production and pathology in rats and mice treated with mercuric chloride have been found associated with histocompatibility phenotype, particularly class II antigens. In preliminary studies we have found that in mice, mercuric chloride exposure results in a restricted autoantibody response which targets the nucleolus, particularly the 34 kDa nucleolar antigen fibrillarin, a component of the U3 snRNP particle and a disease specific target of autoantibodies in human scleroderma. Mercuric chloride induces a proliferative response in lymphocytes. We believe that such proliferation, followed by associated with cell death, is a source of immunologic nucleolar material which leads to autoantibody production. It is the aim of this proposal to examine the fate of fibrillarin during cell proliferation following mercuric chloride exposure, and to relate these findings to fibrillarin biology in cells proliferating in the absence of mercuric chloride. Using indexes of cell function such as DNA, RNA and protein synthesis, and immunofluorescence, immunoprecipitation and Western blotting analysis with autoantibodies from scleroderma patients and mice treated with mercuric chloride and a murine antifibrillarin monoclonal autoantibody we will follow the epitope expression, cellular localisation and structure of fibrillarin following lymphocyte stimulation by mercuric chloride. Autoantibodies to other defined cell constituents will be used as reference points in nuclear structure. Identical parameters of fibrillarin biology will be analysed in proliferating lymphocytes following stimulation by mitogens and in mammalian cell culture lines. By analysing the fate of this nucleolar antigen during cell proliferation to mercuric chloride and to natural mitogens an understanding of how a nuclear self- antigen may be rendered immunogenic will be reached. Such observations may have significance on the mechanism of immunogenicity in autoimmunity in general.

Project Start
Project End
Budget Start
Budget End
Support Year
4
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Type
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Malcarne, Vanessa L; Hansdottir, Ingunn; McKinney, Ann et al. (2007) Medical signs and symptoms associated with disability, pain, and psychosocial adjustment in systemic sclerosis. J Rheumatol 34:359-67
Leake, John A D; Albani, Salvatore; Kao, Annie S et al. (2004) Acute disseminated encephalomyelitis in childhood: epidemiologic, clinical and laboratory features. Pediatr Infect Dis J 23:756-64
Meyer, Markus; Belke, Darrell D; Trost, Susanne U et al. (2004) A recombinant antibody increases cardiac contractility by mimicking phospholamban phosphorylation. FASEB J 18:1312-4
Groessl, Erik J; Kaplan, Robert M; Cronan, Terry A (2003) Quality of well-being in older people with osteoarthritis. Arthritis Rheum 49:23-8
Kaplan, Robert M (2003) The significance of quality of life in health care. Qual Life Res 12 Suppl 1:3-16
Johnson, Kristen; Goding, James; Van Etten, Deborah et al. (2003) Linked deficiencies in extracellular PP(i) and osteopontin mediate pathologic calcification associated with defective PC-1 and ANK expression. J Bone Miner Res 18:994-1004
La Cava, Antonio; Massa, Margherita; Mendivil, Alberto et al. (2002) Genetic immunization maps T cell (auto)immune responses to self antigens homologous to exogenous proteins. Autoimmunity 35:105-10
Prakken, Berent J; Roord, Sarah; van Kooten, Peter J S et al. (2002) Inhibition of adjuvant-induced arthritis by interleukin-10-driven regulatory cells induced via nasal administration of a peptide analog of an arthritis-related heat-shock protein 60 T cell epitope. Arthritis Rheum 46:1937-46
Kaplan, Robert M (2002) Quality of life: an outcomes perspective. Arch Phys Med Rehabil 83:S44-50
Silverman, Gregg J; Goodyear, Carl S (2002) A model B-cell superantigen and the immunobiology of B lymphocytes. Clin Immunol 102:117-34

Showing the most recent 10 out of 94 publications